Our research group has a strong interest in synthesis and the medicinal chemistry of Main Group and Lanthanoid elements, with an emphasis on drug discovery and the design of new theranostic agents. We are very interested in exploiting the unique properties of boron and gadolinium in cutting-edge cancer therapies, and their incorporation into unique molecular scaffolds for binding to important biological receptors or as new biological fluorophores.
Our research has received funding from organizations including the Australian Research Council, The Prostate Cancer Foundation of Australia, Cure Cancer Australia Foundation and The National Breast Cancer Foundation.
